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1. Introduction 
The prevalence of atrial fibrillation (AF) increases as age advances, especially over 65 years 
old.1,2 Given AF occurs, the risk of mortality increases because AF is able to cause 
thromboembolism and heart failure.3-5 In industrialized countries, a number of patients with 
AF need medical care, which has brought a social problem in terms of medical expenses. 
Therefore, it is so important to prevent the occurrence of AF and predict who more likely 
develop AF. Epidemiological studies6-8 revealed that the risk factors for AF development are 
aging, gender, valvular heart disease, hypertension, chronic lung disease, and left atrial size, 
and so forth. In addition, smoking9 and obesity10 are closely associated with the 
development of AF. Needless to say, 12-lead ECG is used ubiquitously in clinical practice to 
evaluate patients and provides information on the presence of structural heart disease and 
heart rhythm abnormality. Moreover, P-wave morphological characteristics deserve noting 
that the pattern of atrial depolarization is normal or ill. In this chapter, we focus on the 
relation between P-wave characteristics and AF occurrence. 
2. P Mitrale and AF 
The P wave reflects electrical depolarization of both the right atrium (RA) and the left 
atrium (LA). When the P wave is biphasic in lead V1 (Figure 1), the positive initial portion 
and the negative terminal portion of the P wave represent depolarization of the RA and the 
LA, respectively.11, 12 Since the early description of an asynchrony of atrial depolarization by 
Reynolds,13 several studies reported P-wave abnormality suggesting LA enlargement.14-16 In 
1964, Morris et al.17 advanced this concept as representing LA overload (LAO). They 
proposed that P terminal force >0.04 second in duration and >0.1 mV in depth at lead V1 
was associated with hemodynamically strained LA in various valvular heart diseases. The 
magnitude of the negative terminal potion of the P wave, calculated as the algebraic product 
of the duration and amplitude (P terminal force) in precordial lead V1, was significantly 
larger in patients with various valvular heart diseases than in normal subjects. In their 
study, the P terminal force was associated with mitral valve area and increased LA pressure. 
The magnitude of the P terminal force has been shown to be associated with LA 
enlargement as revealed by transthoracic echocardiography.18, 19 These findings suggest that 
the negative terminal potion of the P wave in lead V1 is a sign of pressure and volume 
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overload in the LA, which may lead to structural and functional remodeling in the LA. 
Because AF often occurs and/or recurs in the remodeled LA,20 the increased P terminal 
force may underlie the generation of AF.  
 
 
Fig. 1. Twelve-lead ECG showing P mitrale in lead V1. 
The increased P terminal force is observed not only in valvular heart diseases but also in 
other heart diseases, including hypertension, myocardial infarction, and cardiomyopathy.21, 
22 As patients with such disorders likely suffer from AF, the increased P terminal force in 
lead V1 has been considered a probable precursor to development of AF. The terminal 
portion of the P wave in lead V1 has been associated with electrical depolarization of the LA 
alone in humans23 and in dogs.24 Using angiocardiography, Miller and Spertus25 showed a 
correlation of marked negative component in leads V1 and V2 with LA enlargement. 
Subsequently, Morris et al17 showed a significant correlation of the magnitude of P terminal 
force with severity of hemodynamic abnormality. The P terminal portion in lead V1 is 
composed of several factors: (1) anatomic shift of the LA to the posterior side by 
hemodynamic strain, (2) enlarged LA size, (3) LA hypertrophy, and (4) reduced conduction 
velocity in the LA.22, 26, 27 These factors are also attributed to prolonged P-wave duration. 
Ishida et al.28 studied relation of LAO with development of AF. They found that the rate of 
AF development was significantly higher in patients with LAO (P terminal force ≥0.06 
second×0.2 mV in lead V1) than in control subjects. In addition, the area of initial portion of 
P wave in lead V1 was larger in patients who developed AF than in those who did not. 
These findings showed that an increased magnitude of P-wave initial force in lead V1 was 
associated with a higher rate of AF development. This finding suggests that when a 
substrate develops in the RA in addition to the LA, susceptibility to the development of AF 
may increase. 
The P-wave features of LAO reflect basic mechanisms underlying AF occurrence in terms of 
electrophysiologic and structural remodeling of the atrium that predisposes to the 
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development of AF. Increased P-wave duration results from either slow conduction or an 
enlarged atrium. The former shortens wavelength, and the latter provides a sufficient area 
for reentry to occur. These pathophysiologic changes are linked to the maintenance of AF.20 
Increased intracardiac pressure of the left ventricle may cause LA remodeling, which is 
likely to occur in patients with structural heart disease. Disturbed transmitral blood flow 
due to elevated diastolic pressure in the left ventricle may induce heterogeneous 
distribution of the atrial refractory period. Structural remodeling, as occurs with interstitial 
fibrosis and connexin redistribution, causes anisotropic conduction or discontinuous 
propagation. In hypertrophied atrial myocytes, triggered activity, such as early and delayed 
afterdepolarizations, is prone to occur, thus AF ensuring in the remodeled atrium.29, 30  
3. P Pulmonale and AF 
It was reported that chronic obstructive pulmonary disease (COPD) complicated AF.31-33 A 
recent study34 acknowledged that multivariate analysis revealed that heart failure, advanced 
age, prior cerebrovascular events, COPD, and hypertension were independently associated 
with progression of paroxysmal to persistent AF in pharmacologically treated patients. When 
chronic obstructive pulmonary disease (COPD) develops, intimal thickening of arterioles, 
intravascular thrombosis, loss of capillaries occur in addition to perivascular inflammation and 
fibrosis,35 causing pulmonary hypertension.36, 37 Under these pathophysiological conditions, 
the right atrial pressure increases, which results in right atrial enlargement, being responsible 
for P pulmonale. In an autopsy study, Berliner and Master reported that subjects with isolated 
left atrial hypertrophy had normal P-wave amplitude; while those with biatrial hypertrophy 
had an increase in P-wave amplitude, although in four cases of isolated right atrial 
hypertrophy, no P-wave abnormalities were noted. Caird and Wilcken38 found a right atrial 
abnormality at autopsy in patients with COPD. Tall P waves with the amplitude ≧0.25 mV in 
inferior leads have been regarded as an ECG sign representing RA overload (RAO).39 
Typically, patients with COPD exhibit vertical P-wave axis with peaked P wave in leads II, III, 
and aVF (P pulmonale) (Figure 2).40, 41 
 
 
Fig. 2. Twelve-lead ECG showing P pulmonale in inferior leads. 
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It was reported that P pulmonale was associated with impaired pulmonary function 
worsens.42 Asad et al.43 reported that P-wave amplitude in inferior leads decreased in most 
patients with COPD after the acute exacerbations subsided. Saha et al.44 reported that right 
atrial enlargement or increased right atrial pressure or both are important factors for the 
change of the P waves in cor pulmonale. However, little correlation between P pulmonale 
and abnormality of ventilator function in patients with chronic bronchitis was reported38. 
Maeda et al.45 measured intracardiac pressure using Swan-Ganz catheter in patients with P 
pulmonale. In these, no significant increase of intracardiac pressure in right-sided chambers 
was found. However, there was a significant inverse relation between the presence of P 
pulmonale and the cardiothoracic ratio. These findings indicated that a vertical anatomical 
position of the heart was attributed to generation of P pulmonale in COPD rather than 
hemodynamic stress in the right-sided chambers.   
As mentioned above, traditional ECG criteria for P pulmonale are increased amplitudes of P 
waves ≧2.5 mm in leads II, III, and aVF. Such characteristics, however, have been criticized as 
nonspecific for COPD. Chou and Helm46 used the term "pseudo P pulmonale" to explain cases 
where left atrial forces contributed to increased P-wave amplitude in lead II, indicating that P 
pulmonale is not so specific as has been generally believed. Alternative criteria were proposed 
for identifying RAO. Macruz et al.47 investigated that the ratio of P-wave duration to PR 
interval (P/PR) in normal subjects and patients with RAO and LAO. In RAO, the P/PR 
increases because of increased transit time from the sinus node to the atrioventricular node. In 
LAO, the terminal portion of the P wave is delayed because of the prolonged transit time of 
the depolarization impulse through the enlarged left atrial wall. Hence, the P-wave duration is 
prolonged, but P-R interval remains unchanged, resulting in the P/PR above the normal limit. 
Several investigators studied the feasibility of the RAO criteria by determining the size of the 
RA on imaging. Reeves et al.48 determined RA size with two-dimensional echocardiography 
using the apical four-chamber view. They found that RA enlargement was present only in 18% 
of patients with P pulmonale. However, a qR pattern in lead V1 was a significant marker for 
detecting RA enlargement and a positive linear correlation of RA size with the ratio of total 
QRS amplitude in lead V2 compared with lead V1. Kaplan et al.49 determined the size of the 
right atrium using quantitative two-dimensional echocardiography in patients with right atrial 
enlargement. They found that traditional ECG criteria for RAO were insensitive. Instead, a P 
wave height >0.15 mV in lead V2 and, a QRS axis >90 degree and an R/S ratio >1 in lead V1 in 
the absence of complete right bundle branch block best predicted right atrial enlargement. 
Recently, Tsao et al.50 compared anatomic atrial enlargement as determined by volumetric 
cardiovascular magnetic resonance with ECG findings concurrent to criteria of RAO. They 
found that the presence of at least one ECG criteria for P pulmonale is sensitive but not specific 
for anatomic enlargement. 
4. Atrial conduction delay and AF 
Delayed inter- or intra-atrial conduction time predisposes subjects to the development of 
AF.51-53 Histology marked by interstitial fibrosis,54-56 uncoupling of muscle bundle,57 altered 
distribution of gap junction,58, 59 and inflammation60 underlies slow conduction, giving rise 
to P wave prolongation. Several studies61-68 determined P-wave duration. The maximum P-
wave duration varied approximately from 90 ms to 120 ms. Prolonged P-wave duration is a 
useful predictor of AF development.63, 69 Prolonged P-wave duration phenotypically 
represent conduction delay in the atria (Figure 3). A positive correlation between advancing 
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age and P-wave duration was noted.70, 71 Slowed interatrial conduction velocity has been 
demonstrated in a cohort with a history of AF, underscoring the importance of atrial 
conduction delay.72 Many studies reported intimate association of P-wave duration and 
occurrence of AF.63, 73, 74 In addition to P-wave duration, P-wave dispersion, as is reflected as 
the interval between the longest and the shortest duration of P wave in any of 12-lead ECG 
leads, is an invariable maker in relation to AF occurrence and recurrence.73 Both indices are 
associated with conventional risk factors of AF. Patients with uncontrolled hypertension 
had significantly prolonged P-wave duration and increased P-wave dispersion as compared 
to controls or controlled hypertension.75, 76 Likewise, patients with diabetes had significantly 
prolonged P-wave duration and increased P-wave dispersion as compared to normal 
controls.77 Several studies showed that individuals with obesity had significantly prolonged 
P-wave duration and increased P-wave dispersion as compared with control groups.78, 79 
Because those risk factors are independently related to AF occurrence, P-wave duration can 
be used as a noninvasive marker predicting AF occurrence. 
 
 
Fig. 3. Twelve-lead ECG showing prolonged P-wave duration of 156 ms. 
Intraatrial and interatrial conduction delay prolongs duration of P wave and affects 
configuration of P wave. Although P-wave duration on 12-lead ECG is able to be measured by 
computerized assessment, signal averaging technique of body surface ECG provides ability to 
detect small amplitudes <1 µV of P wave. Since electrograms are composed by hundreds of 
data points in signal averaging ECG (SAECG), the onset and offset of P wave are appreciated 
with high reliability and accuracy. The filtered P-wave duration by SAECG was significantly 
longer in patients with paroxysmal AF than in controls, and the amplitude of atrial late 
potential for the last 10-20 ms of P wave significantly lower in patients with paroxysmal AF 
than in controls.80 Thus, patients at risk for paroxysmal AF can be evaluated by SAECG while 
in sinus rhythm.81 The role of P-wave SAECG was further investigated. Prolonged P wave on 
SAECGs was associated with recurrence of AF after cardioversion82  and occurrence of AF 
after cardiothoracic surgery.83 In addition, P-wave duration on SAECG was longer in 
hypertensive patients with paroxysmal AF than in those without.84 Prolonged P-wave 
duration on SAECG exerted to predict future transition from paroxysmal to persistent AF.85 
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5. Conclusion 
P-wave measures can be noninvasively obtained from patients having any disease, if they 
have sinus rhythm. In clinical practice, it is possible to utilize data of ECG recordings for 
various study designs such as cross-sectional, case-control, and intervention studies. 
Therefore, the P-wave analysis needs to be used not only for a diagnostic tool but also to 
evaluate the prognostic value for AF development in the future study. 
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